Company Profile: Oncosil Medical Limited (ASX: OSL) is under health care sector which is into the Oncology Research and Development. It is a device-based company focused on treatments for patients with cancer and is also engaged into the development of lead product candidate, the Oncosil localized radiation therapy. With regards to commercialization, the company has been focusing on an application Conformite Europeene mark for European Union. The company was incorporated in 2005.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report